90 related articles for article (PubMed ID: 25948303)
1. [Role of Scaffold Proteins in Functional Alteration of Small Intestinal P-glycoprotein by Anti-cancer Drugs].
Kobori T; Harada S; Nakamoto K; Tokuyama S
Yakugaku Zasshi; 2015; 135(5):687-95. PubMed ID: 25948303
[TBL] [Abstract][Full Text] [Related]
2. Activation of ERM-family proteins via RhoA-ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia.
Kobori T; Harada S; Nakamoto K; Tokuyama S
J Pharm Sci; 2013 Mar; 102(3):1095-105. PubMed ID: 23303573
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent changes in the activation of RhoA/ROCK and ERM/p-ERM in the increased expression of intestinal P-glycoprotein by repeated oral treatment with etoposide.
Kobori T; Harada S; Nakamoto K; Tokuyama S
J Pharm Sci; 2013 May; 102(5):1670-82. PubMed ID: 23508810
[TBL] [Abstract][Full Text] [Related]
4. RhoA affects oral morphine analgesia depending on functional variation in intestinal P-glycoprotein induced by repeated etoposide treatment.
Kobori T; Kobayashi M; Harada S; Nakamoto K; Fujita-Hamabe W; Tokuyama S
Eur J Pharm Sci; 2012 Dec; 47(5):934-40. PubMed ID: 22982667
[TBL] [Abstract][Full Text] [Related]
5. [Effect of repeated oral treatment with etoposide on the expression of intestinal P-glycoprotein and oral morphine analgesia].
Kobori T; Harada S; Nakamoto K; Tokuyama S
Yakugaku Zasshi; 2014; 134(6):689-99. PubMed ID: 24882643
[TBL] [Abstract][Full Text] [Related]
6. Etoposide modulates the effects of oral morphine analgesia by targeting the intestinal P-glycoprotein.
Fujita-Hamabe W; Nishida M; Nawa A; Kobori T; Nakamoto K; Kishioka S; Tokuyama S
J Pharm Pharmacol; 2012 Apr; 64(4):496-504. PubMed ID: 22420656
[TBL] [Abstract][Full Text] [Related]
7. Changes in PtdIns(4,5)P2 induced by etoposide treatment modulates small intestinal P-glycoprotein via radixin.
Kobori T; Harada S; Nakamoto K; Tokuyama S
Biol Pharm Bull; 2014; 37(7):1124-31. PubMed ID: 24989004
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PtdIns(4,5)P2 in the regulatory mechanism of small intestinal P-glycoprotein expression.
Kobori T; Harada S; Nakamoto K; Tokuyama S
J Pharm Sci; 2014 Feb; 103(2):743-51. PubMed ID: 24311454
[TBL] [Abstract][Full Text] [Related]
9. Radixin influences the changes in the small intestinal P-glycoprotein by etoposide treatment.
Kobori T; Harada S; Nakamoto K; Tokuyama S
Biol Pharm Bull; 2013; 36(11):1822-8. PubMed ID: 24189426
[TBL] [Abstract][Full Text] [Related]
10. Contribution of radixin to P-glycoprotein expression and transport activity in mouse small intestine in vivo.
Yano K; Tomono T; Sakai R; Kano T; Morimoto K; Kato Y; Ogihara T
J Pharm Sci; 2013 Aug; 102(8):2875-81. PubMed ID: 23754525
[TBL] [Abstract][Full Text] [Related]
11. Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier.
Kobori T; Fujiwara S; Miyagi K; Harada S; Nakamoto K; Nakagawa T; Takahashi H; Narita M; Tokuyama S
Drug Metab Pharmacokinet; 2014; 29(6):482-9. PubMed ID: 25048710
[TBL] [Abstract][Full Text] [Related]
12. Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins.
Yano K; Otsuka K; Kato Y; Kawabata H; Ohmori S; Arakawa H; Ogihara T
J Pharm Pharmacol; 2016 Mar; 68(3):361-7. PubMed ID: 26888084
[TBL] [Abstract][Full Text] [Related]
13. Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells.
Kano T; Wada S; Morimoto K; Kato Y; Ogihara T
J Pharm Sci; 2011 Dec; 100(12):5308-14. PubMed ID: 21837648
[TBL] [Abstract][Full Text] [Related]
14. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Li X; Choi JS
Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
[TBL] [Abstract][Full Text] [Related]
15. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
[TBL] [Abstract][Full Text] [Related]
16. Rapid Increase of Gastrointestinal P-Glycoprotein Functional Activity in Response to Etoposide Stimulation.
Yano K; Kimura M; Watanabe Y; Ogihara T
Biol Pharm Bull; 2021; 44(5):701-706. PubMed ID: 33952826
[TBL] [Abstract][Full Text] [Related]
17. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.
Zhao G; Huang J; Xue K; Si L; Li G
Eur J Pharm Sci; 2013 Nov; 50(3-4):429-39. PubMed ID: 23981337
[TBL] [Abstract][Full Text] [Related]
18. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
19. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal Hormone Cholecystokinin Increases P-Glycoprotein Membrane Localization and Transport Activity in Caco-2 Cells.
Yano K; Shimizu S; Tomono T; Ogihara T
J Pharm Sci; 2017 Sep; 106(9):2650-2656. PubMed ID: 28411043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
